-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KuKqAPrkWnC5h5fxDie0AMGTeS8vutd4hlDw/42HAP/9f8LLtP50/CsXi/ye/FFX Ko8lPmF4tEXP53xlVk3N0g== 0001104659-06-035162.txt : 20060515 0001104659-06-035162.hdr.sgml : 20060515 20060515172902 ACCESSION NUMBER: 0001104659-06-035162 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20060515 DATE AS OF CHANGE: 20060515 EFFECTIVENESS DATE: 20060515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REMEDYTEMP INC CENTRAL INDEX KEY: 0001013467 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363] IRS NUMBER: 952890471 STATE OF INCORPORATION: CA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 000-20831 FILM NUMBER: 06843077 BUSINESS ADDRESS: STREET 1: 101 ENTERPRISE CITY: SLISO VIEJO STATE: CA ZIP: 92656 BUSINESS PHONE: 9494257600 MAIL ADDRESS: STREET 1: 101 ENTERPRISE CITY: ALISO VIEJO STATE: CA ZIP: 92656 DEFA14A 1 a06-11974_1defa14a.htm DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

SCHEDULE 14A

 

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.     )

 

Filed by the Registrant  ý

 

Filed by a Party other than the Registrant  o

 

Check the appropriate box:

o

Preliminary Proxy Statement

o

Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

o

Definitive Proxy Statement

o

Definitive Additional Materials

ý

Soliciting Material Pursuant to §240.14a-12

 

Remedy Temp, Inc.

(Name of Registrant as Specified In Its Charter)

 

 

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check the appropriate box):

ý

No fee required.

o

Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

 

(1)

Title of each class of securities to which transaction applies:

 

 

 

 

(2)

Aggregate number of securities to which transaction applies:

 

 

 

 

(3)

Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):

 

 

 

 

(4)

Proposed maximum aggregate value of transaction:

 

 

 

 

(5)

Total fee paid:

 

 

 

o

Fee paid previously with preliminary materials.

o

Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.

 

(1)

Amount Previously Paid:

 

 

 

 

(2)

Form, Schedule or Registration Statement No.:

 

 

 

 

(3)

Filing Party:

 

 

 

 

(4)

Date Filed:

 

 

 

 


 

Hello my friends-

 

I was able to connect with Steve Sorenson, the CEO of Select last night.  We had a very positive conversation.

 

As we all worked through the shock of the news and began to process what it might mean for our businesses, I was encouraged by so many of you as you expressed optimism in our future together, and in your confidence in our franchise leadership team and FAC leaders.  Many asked if extended franchise contracts could be signed immediately.  Truly, you are an inspiration to us.

 

You are a strong, committed group of remarkable people.  What you think and feel is very important to us.  We want to make sure that all your questions and concerns are addressed.  If you have not already communicated with one of us, please take a few moments this weekend to thoughtfully consider items important to you, then email your input to Deborah, Natalie, Melissa, Carolyn, your FAC leader or me.*

 

During the roadshows we talked about leadership, and about building top performing teams.  We realized again how sharing our strength and experience with each other will lead us to even greater success.  And now we have a defining moment - a true leadership opportunity to be rock solid for our employees, associates and clients.  Please join us in creating an environment of open communication, positive anticipation and genuine confidence in our future.

 

Natalie, Deborah and I are united in our enthusiasm about the franchise group’s opportunities in this new chapter of our Remedy story.  There are many advantages of becoming a private company once again, being able to leverage both company’s best practices, and of being a part of a billion dollar organization.

 

We will have our Executive Briefing call as scheduled next week, Wednesday, 10am PST.  And yes, we will have a conference this fall.  So, let’s get back to building our businesses.  We have a few things to accomplish between now and then.

 

Remedy Franchise Division Rocks!

 

Your biggest fan -

 

Janet

 

P.S. Congrats to everyone on a terrific week last week. 18% y/y growth in GM$, 14% up in billings, and GM% of 20.5%

 

P.P.S.  Leadership groups will begin in June. Stay tuned.

 

P.P.P.S.  Don’t forget - watch the new recruiting training module this week!

 


 

Additional Information and Where to Find It

 

RemedyTemp has agreed to file a proxy statement in connection with the proposed acquisition. The proxy statement will be mailed to the shareholders of RemedyTemp. RemedyTemp’s shareholders are urged to read the proxy statement and other relevant materials when they become available because they will contain important information about the acquisition and RemedyTemp.

 

Investors and security holders may obtain free copies of these documents (when they are available) and other documents filed with the Securities and Exchange Commission at the SEC’s web site at www.sec.gov. In addition, investors and security holders may obtain free copies of the documents filed with the SEC by RemedyTemp by going to RemedyTemp’s Investor Relations page on its corporate website at www.remedytemp.com <http://www.remedytemp.com/> .  RemedyTemp and its officers and directors may be deemed to be participants in the solicitation of proxies from RemedyTemp’s shareholders with respect to the acquisition. Information about RemedyTemp executive officers and directors and their ownership of RemedyTemp common stock is set forth in the proxy statement for the RemedyTemp 2006 Annual Meeting of Shareholders, which was filed with the SEC on January 13, 2006. Investors and security holders may obtain more detailed information regarding the direct and indirect interests of RemedyTemp and its respective executive officers and directors in the acquisition by reading the preliminary and definitive proxy statements regarding the merger, which will be filed with the SEC.

 

 -----END PRIVACY-ENHANCED MESSAGE-----